Results 161 to 170 of about 836,416 (221)

Nanobody-enhanced chimeric antigen receptor T-cell therapy: overcoming barriers in solid tumors with VHH and VNAR-based constructs. [PDF]

Biomark Res
Guo S, Xi X.
europepmc   +1 more source

A new era in melanoma immunotherapy: focus on DCs metabolic reprogramming. [PDF]

Cancer Cell Int
Nour MA, Rajabivahid M, Mehdi MSS, Tahmasebi S, Dashtgol SN, Dehghani-Ghorbi M, Vanan AG, Ghorbaninezhad F.   +7 more
europepmc   +1 more source

Strategies for Altering Delivery Technologies to Optimize CAR Therapy. [PDF]

Int J Mol Sci
Cao L, Liu Y, Lin G.
europepmc   +1 more source

A Comprehensive Review About the Use of Monoclonal Antibodies in Cancer Therapy. [PDF]

Antibodies (Basel)
Justiz-Vaillant A, Pandit BR, Unakal C, Vuma S, Akpaka PE.   +4 more
europepmc   +1 more source

Thermal potentiation improves IFN-γ production but not cytotoxicity in human CAR-T cells. [PDF]

BMC Res Notes
Pati NB, Jin Y, Kumar S, Kyte JA, Ciosk R.   +4 more
europepmc   +1 more source

Decoding B Cells in Autoimmune Diseases Through ScRNA + BCR-Seq: Current Knowledge and Future Directions. [PDF]

Cells
Quan K, Wang H, Su P, Xu Y, Yao X.
europepmc   +1 more source

The Emerging Mechanisms and Therapeutic Potentials of Dendritic Cells in NSCLC. [PDF]

J Inflamm Res
Zhou J, Zhao L, Liu L, He L, Chen Y, Wang F, Cui D, Wang L, Zhou Q.   +8 more
europepmc   +1 more source

Overcoming antigen loss in CAR T therapy with Vγ9Vδ2 CAR T-cells. [PDF]

Immunooncol Technol
Velasco Santiago M, Aehnlich P, Hulen TM, Jensen KM, Holmen Olofsson G, Met Ö, Thor Straten P.   +6 more
europepmc   +1 more source

Immunocytes in the tumor microenvironment: recent updates and interconnections. [PDF]

Front Immunol
Yu J, Fu L, Wu R, Che L, Liu G, Ran Q, Xia Z, Liang X, Zhao G.   +8 more
europepmc   +1 more source